The Democratic Republic of the Congo (DRC) Ministry of Health (MOH) reported Friday (computer translated) that the death toll from the Ebola Virus Disease (EVD) outbreak has surpassed 1,000 total.
To date, more than 1500 total cases have been reported. The overall case fatality rate of the epidemic is 65.9 percent.
DRC MOH reports that the majority of cases and deaths are concentrated geographically in and around Butembo. Out of a total of 1,529 cases, 674 (or 44%) were notified in the two health zones that make up the town of Butembo, namely Katwa and Butembo.
Moreover, it is also the city of Butembo that has the heaviest record in terms of loss of life because more than half of the deaths occurred in the town of Butembo. Of 1,008 deaths, 523 (or 51.9%) were reported in the health zones of Butembo and Katwa.
To make matters worse and more difficult, The World Health Organization (WHO) says the operating environment has become increasingly insecure and socio-politically complex. Insecurity remains a major impediment to ensuring timely response interventions in the affected communities.
Ebola virus disease (EVD) response activities in Butembo and Katwa remained limited; however, these are gradually resuming following a comprehensive reinforcement of security measures and community engagement efforts. The overall security situation, nevertheless, remains volatile.
Michael Ryan, MD, with WHO reported that there have been 119 separate violent attacks in the region since January.
Forty-two of those attacks specifically targeting health facilities. Dozens of health workers have been injured or killed.
- Nepal reports 1st human H5N1 avian influenza death
- New York City measles outbreak tops 400 cases
- Measles case onboard Scientology cruise ship, quarantined in St. Lucia
- Mayaro virus situation in the Americas 2019 to date: Peru, Ecuador
- Tennessee measles tally now at 5
- White-nose syndrome: Vaccination may reduce the impact of destructive fungal disease
- Denmark reports Yersinia enterocolitica outbreak
- Dengue vaccine, Dengvaxia receives FDA nod for endemic regions
- Lyme ‘persister’ bacteria and a three-antibiotic cocktail: A study